SoftMedx Healthcare Limited has announced a further extension to the long stop date of its restructuring agreement, now set for 31 December 2025. This decision comes after discussions with the Investor, acknowledging the additional time needed to meet the Resumption Conditions mandated by the SFC and the Stock Exchange. The original deadline was 30 June 2025. Conditions (d), (e), (f), and (g) of the agreement remain unfulfilled, but both parties are committed to completing the restructuring. Trading in the company's shares remains suspended, and stakeholders are advised to exercise caution.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。